A microbial metabolite long linked to cardiovascular risk emerges as a surprising ally against metabolic inflammation, revealing how gut–host signaling can reset glucose control by targeting a single immune kinase.
Study:
Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
